blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1750703

EP1750703 - METHOD FOR REDUCING GASTROINTESTINAL TOXICITY DUE TO THE ADMINISTRATION OF TEGAFUR [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.11.2012
Database last updated on 15.06.2024
Most recent event   Tooltip16.11.2012No opposition filed within time limitpublished on 19.12.2012  [2012/51]
Applicant(s)For all designated states
TAIHO PHARMACEUTICAL CO., LTD.
1-27, Kandanishiki-cho, Chiyoda-ku
Tokyo 101-0054 / JP
[2007/07]
Inventor(s)01 / TAHARA, Takeshi
45-1-301 Mitakedai
Aoba-ku
Yokohama-shi, Kanagawa 2270047 / JP
02 / AMBE, Hiroshi
3-15-24, Nishi-ohi
Shinagawa-ku, Tokyo 1400015 / JP
03 / KURITANI, Jun
6 Hullet Road 08-01 Hullet Rise, Singapore
229159 / SG
04 / NOMURA, Naruo
DECEASED / JP
 [2012/02]
Former [2007/07]01 / TAHARA, Takeshi
45-1-301 Mitakedai, Aoba-ku
Yokohama-shi, Kanagawa 2270047 / JP
02 / AMBE, Hiroshi
3-15-24, Nishi-ohi
Shinagawa-ku, Tokyo 1400015 / JP
03 / KURITANI, Jun
6 Hullet Road 08-01 Hullet Rise, Singapore
229159 / SG
04 / NOMURA, Naruo
DECEASED / JP
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastrasse 30
81925 München / DE
[N/P]
Former [2012/02]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Former [2008/31]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Former [2007/07]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Application number, filing date05738545.227.04.2005
[2007/07]
WO2005JP08450
Priority number, dateUS20040566180P29.04.2004         Original published format: US 566180 P
[2007/07]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005105086
Date:10.11.2005
Language:EN
[2005/45]
Type: A1 Application with search report 
No.:EP1750703
Date:14.02.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 10.11.2005 takes the place of the publication of the European patent application.
[2007/07]
Type: B1 Patent specification 
No.:EP1750703
Date:11.01.2012
Language:EN
[2012/02]
Search report(s)International search report - published on:JP10.11.2005
(Supplementary) European search report - dispatched on:EP30.01.2008
ClassificationIPC:A61K31/4412, A61K31/513, A61K31/53, A61K45/00, A61P35/00, // A61K47/22
[2008/09]
CPC:
A61K31/4412 (EP,US); A61K31/513 (EP,US); A61K31/53 (EP,US);
A61K45/06 (EP,US); A61P1/00 (EP); A61P1/04 (EP);
A61P29/00 (EP); A61P35/00 (EP); A61P43/00 (EP) (-)
C-Set:
A61K31/4412, A61K2300/00 (EP,US);
A61K31/513, A61K2300/00 (US,EP);
A61K31/53, A61K2300/00 (US,EP)
Former IPC [2007/07]A61K31/4412, A61K31/513, A61K31/53, A61K45/00, A61P35/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/07]
Extension statesAL28.11.2006
BA28.11.2006
HR28.11.2006
LV28.11.2006
MK28.11.2006
YU28.11.2006
TitleGerman:VERFAHREN ZUR VERRINGERUNG DER GASTROINTESTINALEN TOXIZITÄT DURCH VERABREICHUNG VON TEGAFUR[2007/07]
English:METHOD FOR REDUCING GASTROINTESTINAL TOXICITY DUE TO THE ADMINISTRATION OF TEGAFUR[2007/07]
French:PROCÉDÉ SERVANT À RÉDUIRE LA TOXICITÉ GASTRO-INTESTINALE DUE À L'ADMINISTRATION DE TÉGAFUR[2007/07]
Entry into regional phase28.11.2006National basic fee paid 
28.11.2006Search fee paid 
28.11.2006Designation fee(s) paid 
28.11.2006Examination fee paid 
Examination procedure28.11.2006Amendment by applicant (claims and/or description)
28.11.2006Examination requested  [2007/07]
18.07.2008Despatch of a communication from the examining division (Time limit: M06)
26.01.2009Reply to a communication from the examining division
19.10.2009Despatch of a communication from the examining division (Time limit: M06)
23.04.2010Reply to a communication from the examining division
11.08.2011Communication of intention to grant the patent
28.11.2011Fee for grant paid
28.11.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  18.07.2008
Opposition(s)12.10.2012No opposition filed within time limit [2012/51]
Fees paidRenewal fee
27.04.2007Renewal fee patent year 03
25.03.2008Renewal fee patent year 04
24.04.2009Renewal fee patent year 05
23.03.2010Renewal fee patent year 06
28.04.2011Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[DPX]  - PETERS G J ET AL, "The effect of food on the pharmacokinetics of S-1 after single oral administration to patients with solid tumors", CLINICAL CANCER RESEARCH 15 JUL 2004 UNITED STATES, (20040715), vol. 10, no. 12 I, ISSN 1078-0432, pages 4072 - 4076, XP002464280 [DPX] 1-32 * the whole document *

DOI:   http://dx.doi.org/10.1158/1078-0432.CCR-1076-03
 [DXY]  - PETERS G J ET AL, "Pharmacokinetics of S-1, an oral formulation of ftorafur, oxonic acid and 5-chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumors", CANCER CHEMOTHERAPY AND PHARMACOLOGY 01 JUL 2003 GERMANY, (20030701), vol. 52, no. 1, ISSN 0344-5704, pages 1 - 12, XP002464281 [DX] 1-5,7-10,14-19,21-32 * page 2, column R, paragraph 4 * [Y] 1-32

DOI:   http://dx.doi.org/10.1007/s00280-003-0617-9
 [Y]  - DAMLE B ET AL, "Effect of food on the oral bioavailability of UFT and leucovorin in cancer patients", CLINICAL CANCER RESEARCH 2001 UNITED STATES, (2001), vol. 7, no. 3, ISSN 1078-0432, pages 517 - 523, XP002464282 [Y] 1-32 * abstract *
International search[X]EP0543015  (TAIHO PHARMACEUTICAL CO LTD [JP]);
 [X]  - SAKATA Y. ET AL, EUR J CANCER., (1998), vol. 34, no. 11, pages 1715 - 1720, XP004285120

DOI:   http://dx.doi.org/10.1016/S0959-8049(98)00211-1
 [X]  - CHOLLET P. ET AL, EUR J CANCER., (2003), vol. 39, no. 9, pages 1264 - 1270, XP004425218

DOI:   http://dx.doi.org/10.1016/S0959-8049(03)00237-5
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.